Yıl: 2021 Cilt: 69 Sayı: 2 Sayfa Aralığı: 177 - 186 Metin Dili: İngilizce DOI: 10.5578/tt.20219807 İndeks Tarihi: 01-06-2022

Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings

Öz:
Introduction: COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). Materials and Methods: In the present study, 74 patients who admitted to the emergency department with respiratory distress during the pandemic period and received a diagnosis of COVID-19 pneumonia and AHF were included. Laboratory data and radiological findings of the patients, at the time of admission, were evaluated. Results: On admission, there was no difference in age, gender between two groups. However, COVID-19 exposure history was found significantly higher in COVID-19 pneumonia patients group (p< 0.001). Fever, cough, and fatigue were found significantly higher in the COVID-19 pneumonia patients group (p< 0.001). There was difference of lesions distribution between the two groups, centrally distributed lesions were found significantly higher in acute heart failure patients (p< 0.001). Pleural effusion and cardiomegaly were found significantly higher in AHF patients (p< 0.001, p< 0.001). Counts of the white blood cells and lymphocytes were found significantly lower in COVID-19 pneumonia patients (p= 0.003, p= 0.009). COVID-19 pneumonia patients had significantly higher levels of CRP, ferritin, LDH and CK compared with AHF patients (p< 0.001, p< 0.001, p= 0.002, p= 0.013). However the level of NT-proBNP was found significantly higher in the AHF patients group (p< 0.001). Conclusion: We believe that laboratory data and thorax CT findings can provide beneficial clinical information in differentiating COVID-19 pneumonia from AHF during the pandemic
Anahtar Kelime:

Pandemide COVID-19 pnömonisinin akut kalp yetmezliğinden ayırıcı tanısı: Radyolojik bulguların ve laboratuvar bulgularının önemi

Öz:
Giriş: COVID-19 pnömonisi tipik olarak yüksek ateş, öksürük, nefes darlığı ile klinik prezente olmakta ve toraks BT’de periferal buzlu cam dansitelerinin görülmesi tanıya yardımcı olmaktadır. Her ne kadar toraks BT’de COVID-19 pnömonisi için tipik görüntüleme bulguları belirtilmiş olsa da, COVID-19 pnömonisinin toraks BT görüntüleme bulguları birçok hastalık ile karışabilmektedir. Bu çalışmada radyolojik görüntüleme bulgularının ve laboratuvar bulgularının COVID-19 pnömonisi ve akut kalp yetmezliği (AKY) ayırıcı tanısında yerinin olup olmadığının araştırılması amaçlanmıştır. Materyal ve Metod: Çalışmaya pandemi sürecinde acil servise solunum sıkıntısı ile başvuran, COVID-19 pnömonisi ve AKY tanısı alan toplam 74 hasta dahil edilmiştir. Olguların hastaneye başvuru sırasındaki laboratuar verileri ve radyolojik bulguları değerlendirilmiştir. Bulgular: Başvuru sırasında, iki grup arasında yaş ve cinsiyet açısından fark yoktu. Bununla birlikte, COVID-19 maruziyet öyküsü, COVID-19 pnömonisi hasta grubunda anlamlı olarak daha yüksek bulundu (p< 0,001). COVID-19 pnömonisi hasta grubunda ateş, öksürük ve yorgunluk anlamlı olarak yüksek bulundu (p< 0,001). İki grup arasında lezyon dağılımı açısından farklılıklar mevcuttu, santral yerleşim gösteren lezyonlar AKY hastalarında anlamlı olarak daha yüksek bulundu (p< 0,001). AKY hastalarında plevral efüzyon ve kardiyomegali anlamlı olarak yüksek bulundu (p< 0,001, p< 0,001). COVID-19 pnömonisi olgularında lökosit ve lenfosit sayıları anlamlı olarak düşük bulundu (p= 0,003, p= 0,009). COVID-19 pnömonisi hastaları, AKY hastalarına kıyasla anlamlı olarak daha yüksek CRP, ferritin, LDH ve CK seviyelerine sahipti (p< 0,001, p< 0,001, p= 0,002, p= 0,013). Ancak NT-proBNP düzeyi ABY hasta grubunda anlamlı olarak yüksek bulundu (p< 0,001). Sonuç: Laboratuvar verilerinin ve toraks BT bulgularının pandemi sürecinde COVID-19 pnömonisini AKY’den ayırt etmede faydalı klinik bilgiler sağlayabileceğine inanıyoruz.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323(16): 1574-81.
  • 2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients in-fected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
  • 3. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 2020; 323(20): 2052-59.
  • 4. Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy 2020; 75(7): 1699-709.
  • 5. Odabasi Z, Cinel I. Consideration of severe coronavirus disease 2019 as viral sepsis and potential use of immune checkpoint inhibitors. Crit Care Explor 2020; 2(6): e0141.
  • 6. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med 2020. 2020/10/22.
  • 7. Wu Z, McGoogan JM. Characteristics of and important lessons from the corona-virus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA 2020; 323(13): 1239-42.
  • 8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-62.
  • 9. Luo L, Luo Z, Jia Y, Zhou C, He J, Lyu J, et al. CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method. BMC Pulm Med 2020; 20(1): 129.
  • 10. Bertolino L, Vitrone M, Durante-Mangoni E. Does this patient have COVID-19? A practical guide for the internist. Intern Emerg Med 2020; 15(5): 791-800.
  • 11. Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020; 101(5): 263-68.
  • 12. Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the chest CT differential diagnosis of ground-glass opacities in the COVID Era. Radiology 2020: 202504.
  • 13. World Health Organization (WHO). Clinical management of COVID-19: interim guidance. 27 May 2020. Available at https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed (November 10, 2020). Available from: https://www.who.int/publications/i/item/ clinical-management-of-covid-19.
  • 14. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the Euro-pean Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129-200
  • 15. Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, et al. Tim-ing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008; 52(7): 534-40.
  • 16. Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC. Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail 2009; 15(6): 256-64.
  • 17. Ural D, Cavusoglu Y, Eren M, Karauzum K, Temizhan A, Yilmaz MB, et al. Diagno-sis and management of acute heart failure. Anatol J Cardiol 2015; 15(11): 860-89.
  • 18. Zhu Z, Tang J, Chai X, Fang Z, Liu Q, Hu X, et al. How to differentiate COVID-19 pneumonia from heart failure with computed tomography at initial medical contact during epidemic period. medRxiv 2020: 2020.03.04.20031047.
  • 19. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, et al. Rec-ommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 2015; 17(6): 544-58.
  • 20. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with Different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 2020; 201(11): 1380-88.
  • 21. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
  • 22. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3): 105924.
  • 23. Palmieri L, Palmer K, Lo Noce C, Meli P, Giuliano M, Floridia M, et al. Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy. Aging Clin Exp Res 2020.
  • 24. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433.
  • 25. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant 2020; 39(5): 405-07.
  • 26. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cas-es. Radiology 2020; 296(2): E32-E40.
  • 27. Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of chest CT in diagnosis and management. AJR Am J Roentgenol 2020; 214(6): 1280-86.
  • 28. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. Jama 2020; 323(20): 2052-9.
  • 29. Wikramaratna P, Paton RS, Ghafari M, Lourenço J. Estimating false-negative de-tection rate of SARS-CoV-2 by RT-PCR. medRxiv 2020: 2020.04.05.20053355.
  • 30. Duan YN, Zhu YQ, Tang LL, Qin J. CT features of novel coronavirus pneumonia (COVID-19) in children. Eur Radiol 2020; 30(8): 4427-33.
  • 31. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296(2): E115-E17.
  • 32. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of lung changes at chest CT during recovery from Coronavirus Disease 2019 (COVID-19). Radiology 2020; 295(3): 715-21.
  • 33. Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the chest CT Differ-ential Diagnosis of Ground-Glass Opacities in the COVID Era. Radiology 2020; 297(3): E289-E302.
  • 34. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coro-navirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020; 30(8): 4381-9.
  • 35. Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias. Clin Infect Dis 2020; 71(15): 756-61.
  • 36. Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT imaging and differen-tial diagnosis of COVID-19. Can Assoc Radiol J 2020; 71(2): 195-200.
  • 37. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020; 92(7): 791- 96.
  • 38. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020; 510: 475-82.
  • 39. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1091.
  • 40. Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Ye-ganeh B, et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med 2020; 58(3): 161-7.
  • 41. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Prediction for progression risk in patients with COVID-19 pneumonia: The CALL Score. Clin Infect Dis 2020; 71(6): 1393-99.
  • 42. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020; 58(7): 1131-34.
APA Kasapoglu U, Gök A, Acun Delen L, şayan h, KACMAZ O, ÇAĞAŞAR Ö, Karaca R, Güneş A, Pembegul I, YALÇINSOY M (2021). Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. , 177 - 186. 10.5578/tt.20219807
Chicago Kasapoglu Umut Sabri,Gök Abdullah,Acun Delen Leman,şayan hasan,KACMAZ OSMAN,ÇAĞAŞAR ÖZLEM,Karaca Rukan,Güneş Ajda,Pembegul Irem,YALÇINSOY MURAT Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. (2021): 177 - 186. 10.5578/tt.20219807
MLA Kasapoglu Umut Sabri,Gök Abdullah,Acun Delen Leman,şayan hasan,KACMAZ OSMAN,ÇAĞAŞAR ÖZLEM,Karaca Rukan,Güneş Ajda,Pembegul Irem,YALÇINSOY MURAT Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. , 2021, ss.177 - 186. 10.5578/tt.20219807
AMA Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. . 2021; 177 - 186. 10.5578/tt.20219807
Vancouver Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. . 2021; 177 - 186. 10.5578/tt.20219807
IEEE Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M "Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings." , ss.177 - 186, 2021. 10.5578/tt.20219807
ISNAD Kasapoglu, Umut Sabri vd. "Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings". (2021), 177-186. https://doi.org/10.5578/tt.20219807
APA Kasapoglu U, Gök A, Acun Delen L, şayan h, KACMAZ O, ÇAĞAŞAR Ö, Karaca R, Güneş A, Pembegul I, YALÇINSOY M (2021). Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tüberküloz ve Toraks, 69(2), 177 - 186. 10.5578/tt.20219807
Chicago Kasapoglu Umut Sabri,Gök Abdullah,Acun Delen Leman,şayan hasan,KACMAZ OSMAN,ÇAĞAŞAR ÖZLEM,Karaca Rukan,Güneş Ajda,Pembegul Irem,YALÇINSOY MURAT Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tüberküloz ve Toraks 69, no.2 (2021): 177 - 186. 10.5578/tt.20219807
MLA Kasapoglu Umut Sabri,Gök Abdullah,Acun Delen Leman,şayan hasan,KACMAZ OSMAN,ÇAĞAŞAR ÖZLEM,Karaca Rukan,Güneş Ajda,Pembegul Irem,YALÇINSOY MURAT Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tüberküloz ve Toraks, vol.69, no.2, 2021, ss.177 - 186. 10.5578/tt.20219807
AMA Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tüberküloz ve Toraks. 2021; 69(2): 177 - 186. 10.5578/tt.20219807
Vancouver Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings. Tüberküloz ve Toraks. 2021; 69(2): 177 - 186. 10.5578/tt.20219807
IEEE Kasapoglu U,Gök A,Acun Delen L,şayan h,KACMAZ O,ÇAĞAŞAR Ö,Karaca R,Güneş A,Pembegul I,YALÇINSOY M "Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings." Tüberküloz ve Toraks, 69, ss.177 - 186, 2021. 10.5578/tt.20219807
ISNAD Kasapoglu, Umut Sabri vd. "Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings". Tüberküloz ve Toraks 69/2 (2021), 177-186. https://doi.org/10.5578/tt.20219807